19 results found.

Amyotrophic Lateral Sclerosis (ALS) Clinical Trial using Basiliximab; Methylprednisolone; Prednisone; Tacrolimus; Mycophenolate mofetil

Emory University - Recruiting 18 years or older.
- A Novel Immunosuppression Intervention for the Treatment of Amyotrophic Lateral Sclerosis (ALS).
Basiliximab; Methylprednisolone; Prednisone; Tacrolimus; Mycophenolate mofetil

Amyotrophic Lateral Sclerosis (ALS) Clinical Trial using NeuRx® Diaphragm Pacing System™ (DPS)

State University of New York - Upstate Medical University - Recruiting 21 years or older.
- Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS).
NeuRx® Diaphragm Pacing System™ (DPS)

Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Charcot-Mari Clinical Trial using Electrical impedance myography (EIM)

State University of New York - Upstate Medical University - Recruiting 35 years to 80 years.
- Noninvasive Assessment of Neuromuscular Disease Using Electrical Impedance.
Electrical impedance myography (EIM)

Amyotrophic Lateral Sclerosis (ALS) Clinical Trial using Rasagiline; Placebo

University of Kansas - Recruiting 21 years to 80 years.
- Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis IND# 104,360.
Rasagiline; Placebo

Amyotrophic Lateral Sclerosis Clinical Trial using VM202

ViroMed Co., Ltd. dba VM BioPharma - Recruiting 21 years to 75 years.
- A Phase I/II, Open Label Study to Assess the Safety and Tolerability of VM202 in Subjects With Amyotrophic Lateral Sclerosis.
VM202

Amyotrophic Lateral Sclerosis Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Natural History and Biomarkers of C9ORF72 Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Amyotrophic Lateral Sclerosis Clinical Trial using autologous mesenchymal stem cells

Mayo Clinic - Recruiting 18 years or older.
- A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis.
autologous mesenchymal stem cells

Sporadic Amyotrophic Lateral Sclerosis Clinical Trial using Mexiletine; Placebo

University of Washington - Recruiting 18 years or older.
- A Safety and Tolerability Study of Mexiletine in Patients With Sporadic Amyotrophic Lateral Sclerosis (SALS).
Mexiletine; Placebo

Amyotrophic Lateral Sclerosis Clinical Trial using Repository corticotropin injection

Questcor Pharmaceuticals, Inc. - Recruiting 18 years to 80 years.
- A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis.
Repository corticotropin injection

Sialorrhea, or Amyotrophic Lateral Sclerosis Clinical Trial using Botox injection; Placebo injection

Hospices Civils de Lyon - Recruiting 18 years or older.
- Evaluation of Efficacy of Botulinum Toxin Type A in the Treatment of Sialorrhea in the Patient Affected by Amyotrophic Lateral Sclerosis (ALS).
Botox injection; Placebo injection

Amyotrophic Lateral Sclerosis Clinical Trial

Massachusetts General Hospital - Recruiting 18 years to 90 years.
- Longitudinal Study Comparing the Responsiveness of Outcomes Measures in ALS Trials.

Amyotrophic Lateral Sclerosis, Neurodegenerative Disease, or Moto Clinical Trial

Drexel University - Recruiting 18 years or older.
- ALS Tissue Donation Program.

Amyotrophic Lateral Sclerosis Clinical Trial

Carolinas Healthcare System - Recruiting 18 years or older.
- Establishment of a Tissue Bank (Blood, CSF) for the Understanding of the Disease Progression and Early Diagnosis of Motor Neuron Disease (MND)..

Amyotrophic Lateral Sclerosis Clinical Trial

Drexel University - Recruiting 18 years to 89 years.
- Non-Invasive Measurement of GI Motility in Patients With ALS.

Amyotrophic Lateral Sclerosis Clinical Trial using Intrathecal autologous stem cell

Hospital Universitario Dr. Jose E. Gonzalez - Recruiting 18 years or older.
- Effect of Intrathecal Administration of Hematopoietic Stem Cells in Patients With Amyotrophic Lateral Sclerosis (ALS).
Intrathecal autologous stem cell

Amyotrophic Lateral Sclerosis, or Neurodegenerative Diseases Clinical Trial

Drexel University - Recruiting 20 years to 85 years.
- Quantitative Measurement of Nutritional Substrate Utilization in Patients With ALS.

Motor Neuron Disease, or Amyotrophic Lateral Sclerosis (ALS) Clinical Trial using Cannabis Sativa extract Oromucosal spray

Ospedale San Raffaele - Recruiting 18 years to 80 years.
- A Fase II, Randomized, Double-Blind, Placebo-Controlled, Multicentre Study for the Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease Patients.
Cannabis Sativa extract Oromucosal spray

Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Neuromuscula Clinical Trial using HYNR-CS-Allo

Hanyang University Seoul Hospital - Recruiting 25 years to 80 years.
- An Open-label, Phase 1 Trial for Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell('HYNR-CS-Allo Inj') Treatment in Amyotrophic Lateral Sclerosis(ALS).
HYNR-CS-Allo

Amyotrophic Lateral Sclerosis Clinical Trial

University of Miami - Recruiting 18 years or older.
- Familial Amyotrophic Lateral Sclerosis (FALS) Study.